Successful thrombectomy is beneficial in patients with pre-stroke disability: Results from an international multicenter cohort study.
Journal of Neuroradiology. 2023-02-01; 50(1): 59-64
DOI: 10.1016/j.neurad.2022.03.006
Read on PubMed
Ducroux C(1), Derex L(2), Nourredine M(3), Haesebaert J(3), Buisson M(4), Alesefir W(1), Boisseau W(5), Daneault N(6), Deschaintre Y(6), Diestro JDB(5), Eker O(7), Eneling J(5), Gioia LC(6), Iancu D(5), Jacquin G(6), Odier C(6), Stapf C(6), Raymond J(5), Roy D(5), Weill A(5), Lapergue B(8), Poppe AY(9); ETIS (Endovascular Treatment in Ischemic Stroke) Investigators.
Collaborators: Piotin M, Blanc R, Escalard HRS, Desilles JP, Delvoye F, Smajda
S, Maier B, Hebert S, Mazighi M, Obadia M, Sabben C, Seners P, Raynouard I,
Corabianu O, de Broucker T, Manchon E, Taylor G, Ben Maacha M, Thion LA, Lecler
A, Savatovsky J, Wang A, Evrard S, Tchikviladze M, Ajili N, Lapergue B,
Weisenburger-Lile D, Gorza L, Buard G, Coskun O, Consoli A, Di Maria F, Rodesh
G, Zimatore S, Leguen M, Gratieux J, Pico F, Rakotoharinandrasana H, Tassan P,
Poll R, Marinier S, Nighoghossian N, Riva R, Eker O, Turjman F, Derex L, Cho TH,
Mechtouff L, Lukaszewicz AC, Philippeau F, Cakmak S, Blanc-Lasserre K, Vallet
AE, Marnat G, Gariel F, Barreau X, Berge J, Menegon P, Sibon I, Lucas L, Olindo
S, Renou P, Sagnier S, Poli M, Debruxelles S, Rouanet F, Tourdias T, Liegey JS,
Briau P, Pangon N, Bourcier R, Detraz L, Daumas-Duport B, Alexandre PL, Roy M,
Lenoble C, Desal H, Guillon B, de Gaalon S, Preterre C, Gory B, Bracard S,
Anxionnat R, Braun M, Derelle AL, Tonnelet R, Liao L, Zhu F, Schmitt E, Planel
S, Richard S, Humbertjean L, Mione G, Lacour JC, Riou-Comte N, Audibert G, Voicu
M, Alb I, Reitter M, Brezeanu M, Masson A, Tabarna A, Podar I, Macian-Montoro F,
Saleme S, Mounayer C, Rouchaud A, Costalat V, Arquizan C, Dargazanli C, Gascou
G, Lefèvre PH, Derraz I, Riquelme C, Gaillard N, Mourand I, Corti L, Cagnazzo F,
Ter Schiphorst A, Francois E, Vannier S, Ferre JC, Raoult H, Ronziere T, Lassale
M, Paya C, Gauvrit JY, Tracol C, Langnier-Lemercier S, Samson Y, Rosso C, Leger
A, Deltour S, Clarencon F, Shotar E, Spelle L, Denier C, Chassin O, Chalumeau V,
Caroff J, Chassin O, Venditti L, Naggara O, Hassen WB, Boulouis G,
Rodriguez-Régent C, Trystram D, Kerleroux B, Turc G, Domigo V, Lamy C,
Birchenall J, Isabel C, Lun F, Viguier A, Cognard C, Januel AC, Olivot JM,
Raposo N, Bonneville F, Albucher JF, Calviere L, Darcourt J, Tall P, Bellanger
G, Fontaine L, Touze E, Barbier C, Schneckenburger R, Boulanger M, Cogez J,
Guettier S, Timsit S, Gentric JC, Ognard J, Merrien FM, Wermester OO, Massardier
E, Papagiannaki C, Bourdain F, Bernady P, Lagoarde-Segot L, Cailliez H, Veunac
L, Higue D, Wolff V, Pop R, Beaujeux R, Dan-Sorin M, Manisor M, Le Bras A, Evain
S, Le Guen A, Richter S, Hubrecht R, Demasles S, Barroso B, Sablot D, Farouil G,
Tardieu M, Smadja P, Aptel S, Seiler I.
Author information:
(1)Department of Neurosciences, Faculté de médecine, Université de Montréal,
Montréal, QC, Canada; Department of Medicine (Neurology), Centre Hospitalier de
l’Université de Montréal, 900 rue St-Denis, Bureau R04-758, Montréal, QC H2X
0A9, Canada.
(2)Department of Neurology, Stroke Center, Neurological Hospital, Hospices
Civils de Lyon, University of Lyon, France; Research on Healthcare Performance
(RESHAPE), INSERM U1290, University Claude Bernard Lyon 1, Lyon, France.
(3)Department of Research and Epidemiology, Pôle de Santé Publique, Hospices
Civils de Lyon, Lyon, France; Department of pharmaco-toxicology, Hospices Civils
de Lyon, Lyon, France.
(4)Clinical Investigation Center, INSERM 1407, Louis Pradel Hospital, Hospices
Civils de Lyon, Lyon, France.
(5)Department of Radiology, Centre Hospitalier de l’Université de Montréal,
Montréal, QC, Canada.
(6)Department of Neurosciences, Faculté de médecine, Université de Montréal,
Montréal, QC, Canada; Department of Medicine (Neurology), Centre Hospitalier de
l’Université de Montréal, 900 rue St-Denis, Bureau R04-758, Montréal, QC H2X
0A9, Canada; Neurovascular Group, Neurosciences Axis, Centre de Recherche du
Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, QC, Canada.
(7)Department of Neuroradiology, Neurological Hospital, Hospices Civils de Lyon,
Lyon, France.
(8)Department of Neurology, Foch Hospital, Suresnes, France.
(9)Department of Neurosciences, Faculté de médecine, Université de Montréal,
Montréal, QC, Canada; Department of Medicine (Neurology), Centre Hospitalier de
l’Université de Montréal, 900 rue St-Denis, Bureau R04-758, Montréal, QC H2X
0A9, Canada; Neurovascular Group, Neurosciences Axis, Centre de Recherche du
Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, QC, Canada.
Electronic address: .
BACKGROUND: Patients with pre-stroke disability, defined as a modified Rankin
Scale (mRS) ≥3, were excluded from most trials of endovascular thrombectomy
(EVT) for acute stroke. We sought to evaluate the prognostic factors associated
with favorable outcome in stroke patients with known disability undergoing EVT,
and the impact of successful reperfusion.
METHODS: Consecutive acute stroke patients with pre-stroke disability,
undergoing EVT, were retrospectively collected between 2016 to 2019 from a
Canadian cohort and a multicenter French cohort (Endovascular Treatment in
Ischemic Stroke registry-ETIS). Favorable outcome was defined as an mRS equal to
pre-stroke mRS. Patients achieving successful reperfusion (defined as a modified
Thrombolysis in Cerebral Infarction score of 2b/3) were compared with patients
without successful reperfusion to determine if successful EVT was associated
with better functional outcomes.
RESULTS: Among 6220 patients treated with EVT, 280 (4.5%) patients with a
pre-stroke mRS ≥3 were included. Sixty-one patients (21.8%) had a favorable
outcome and 146 (52.1%) died at 3 months. Patients with successful reperfusion
had a higher proportion of favorable 90-day mRS (27.6% versus 19.6%, p = 0.025)
and a lower mortality (48.3% versus 69.6%, p = 0.008) than patients without
successful reperfusion. After adjusting for baseline prognostic factors,
successful reperfusion defined by TICI ≥2b was associated with favorable
functional outcome (OR 3.16 CI95% [1.11-11.5]; p 0.048).
CONCLUSION: In patients with pre-stroke disability, successful reperfusion is
associated with a greater proportion of favorable outcome and lower mortality.
Copyright © 2022 Elsevier Masson SAS. All rights reserved.
DOI: 10.1016/j.neurad.2022.03.006
PMID: 35341899 [Indexed for MEDLINE]
Conflict of interest statement: Declaration of Competing Interest Authors
declare no conflicts of interests.